Inactive Instrument

News Genzyme Corporation

Stocks

US3729171047

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

All News

Mentions Relevance

11-06-28	GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress	PU
11-03-07	GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares	BU
11-03-01	GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	BU
11-02-28	GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program	BU
11-02-18	GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across All Endpoints	BU
11-02-16	GENZYME CORP.GNL : Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year	BU
11-02-01	GENZYME CORP.GNL : Genzyme Completes Sale of Diagnostics Business to Sekisui Chemical Co.	BU
11-01-31	GENZYME CORP.GNL : Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence	BU
11-01-20	GENZYME CORP.GNL : Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®	BU
11-01-11	GENZYME CORP.GNL : Genzyme Financial Recovery Continues in Fourth Quarter	BU
11-01-10	GENZYME CORP.GNL : Genzyme Statement on Discussions With Sanofi-Aventis	BU
10-12-20	GENZYME CORP.GNL : Genzyme Details Market Potential of Alemtuzumab for MS	BU
10-12-13	GENZYME CORP.GNL : Genzyme to Hold Investor Event on Alemtuzumab	BU
10-12-13	GENZYME CORP.GNL : Genzyme Reiterates Board's Position on Sanofi-Aventis Tender Offer	BU
10-12-01	GENZYME CORP.GNL : Genzyme Completes Sale of Genetic Testing Business to LabCorp	BU
10-11-24	GENZYME CORP.GNL : Genzyme Successfully Meets First Milestones of FDA Consent Decree	BU
10-11-18	GENZYME CORP.GNL : Genzyme Announces Agreement to Sell Diagnostics Business to Sekisui Chemical Co.	BU
10-11-08	GENZYME CORP.GNL : Genzyme Responds to Sanofi-Aventis Letter	BU
10-10-22	GENZYME CORP.GNL : Genzyme Details Financial Recovery and Other Factors Driving Company's Value	BU
10-10-21	GENZYME CORP.GNL : Genzyme Announces Webcast of Analyst and Investor Event	BU
10-10-20	GENZYME CORP.GNL : Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML	BU
10-10-20	GENZYME CORP.GNL : Genzyme Reports Financial Results for the Third Quarter of 2010	BU
10-10-14	GENZYME CORP.GNL : Genzyme's Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial	BU
10-10-13	GENZYME CORP.GNL : Genzyme Announces Upcoming Analyst and Investor Events	BU
10-10-07	GENZYME CORP.GNL : Genzyme Board Unanimously Rejects Sanofi-Aventis Tender Offer	BU